17185301

Source:http://linkedlifedata.com/resource/pubmed/id/17185301

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006055, umls-concept:C0008976, umls-concept:C0154676, umls-concept:C1522577
pubmed:issue	3
pubmed:dateCreated	2007-2-19
pubmed:abstractText	Botulinum toxin type A (BoNT-A) has become the treatment of choice for most types of focal dystonia.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-11127535, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-11391744, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-11502904, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-11748761, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-11971047, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-14509660, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-14509685, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-14615682, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-1549227, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-1692172, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-2005922, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-2067643, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-2213039, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-3066430, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-3264051, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-3400503, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-3722399, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-3966004, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-7104663, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-7565828, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-7603232, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-7632082, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-8290095, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-8353672, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-8423882, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-8530982, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-8708685, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-8780093, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-9339715, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-9686779, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-9750918, http://linkedlifedata.com/resource/pubmed/commentcorrection/17185301-9856142
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985191R
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Botulinum Toxins, http://linkedlifedata.com/resource/pubmed/chemical/Neuromuscular Agents
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1468-330X
pubmed:author	pubmed-author:KoelmanJ H T MJH, pubmed-author:KruisdijkJ J MJJ, pubmed-author:Ongerboer de VisserB WBW, pubmed-author:SpeelmanJ DJD, pubmed-author:de HaasR ARA
pubmed:issnType	Electronic
pubmed:volume	78
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	264-70
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:17185301-Adult, pubmed-meshheading:17185301-Botulinum Toxins, pubmed-meshheading:17185301-Double-Blind Method, pubmed-meshheading:17185301-Dystonic Disorders, pubmed-meshheading:17185301-Female, pubmed-meshheading:17185301-Follow-Up Studies, pubmed-meshheading:17185301-Humans, pubmed-meshheading:17185301-Male, pubmed-meshheading:17185301-Middle Aged, pubmed-meshheading:17185301-Neuromuscular Agents, pubmed-meshheading:17185301-Severity of Illness Index, pubmed-meshheading:17185301-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up.
pubmed:affiliation	Department of Neurology and Clinical Neurophysiology, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. j.j.kruisdijk@amc.uva.nl
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't